Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Alpine Immune Sciences Inc, A Subsidiary Of Vertex

Clinical trials sponsored by Alpine Immune Sciences Inc, A Subsidiary Of Vertex, explained in plain language.

Not yet finished but already full! 1

New drug aims to protect kidneys in IgA nephropathy patients

Disease control Ongoing

This phase 3 trial tests whether the drug povetacicept can reduce protein in the urine and preserve kidney function in adults with IgA nephropathy, a kidney disease. About 605 participants will receive either the drug or a placebo by injection. The study is active but not recruit…

Phase: PHASE3 • Sponsor: Alpine Immune Sciences Inc, A Subsidiary of Vertex • Aim: Disease control

Last updated Jun 27, 2026 12:34 UTC